@article{bruggemann.etal_2022b,
  title = {Management of Drug--Drug Interactions of Targeted Therapies for Haematological Malignancies and Triazole Antifungal Drugs},
  author = {Br{\"u}ggemann, Roger J and Verheggen, Rebecca and Boerrigter, Emmy and Stanzani, Marta and Verweij, Paul E and Blijlevens, Nicole M A and Lewis, Russell E},
  year = {2022},
  month = jan,
  journal = {The Lancet Haematology},
  volume = {9},
  number = {1},
  pages = {e58-e72},
  issn = {23523026},
  doi = {10.1016/S2352-3026(21)00232-5},
  urldate = {2022-02-25},
  langid = {english},
  keywords = {Aged,Antifungal Agents,Drug Interactions,Hematologic Neoplasms,Humans,Pharmaceutical Preparations,Triazoles},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/7IQW4ADS/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf;/Users/russelllewis/Zotero/storage/XREGA4SJ/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf}
}

{"_id":"SEkW5rrJmxqC4yYZw","bibbaseid":"brggemann-verheggen-boerrigter-stanzani-verweij-blijlevens-lewis-managementofdrugdruginteractionsoftargetedtherapiesforhaematologicalmalignanciesandtriazoleantifungaldrugs-2022","author_short":["Brüggemann, R. J","Verheggen, R.","Boerrigter, E.","Stanzani, M.","Verweij, P. E","Blijlevens, N. M A","Lewis, R. E"],"bibdata":{"bibtype":"article","type":"article","title":"Management of Drug–Drug Interactions of Targeted Therapies for Haematological Malignancies and Triazole Antifungal Drugs","author":[{"propositions":[],"lastnames":["Brüggemann"],"firstnames":["Roger","J"],"suffixes":[]},{"propositions":[],"lastnames":["Verheggen"],"firstnames":["Rebecca"],"suffixes":[]},{"propositions":[],"lastnames":["Boerrigter"],"firstnames":["Emmy"],"suffixes":[]},{"propositions":[],"lastnames":["Stanzani"],"firstnames":["Marta"],"suffixes":[]},{"propositions":[],"lastnames":["Verweij"],"firstnames":["Paul","E"],"suffixes":[]},{"propositions":[],"lastnames":["Blijlevens"],"firstnames":["Nicole","M","A"],"suffixes":[]},{"propositions":[],"lastnames":["Lewis"],"firstnames":["Russell","E"],"suffixes":[]}],"year":"2022","month":"January","journal":"The Lancet Haematology","volume":"9","number":"1","pages":"e58-e72","issn":"23523026","doi":"10.1016/S2352-3026(21)00232-5","urldate":"2022-02-25","langid":"english","keywords":"Aged,Antifungal Agents,Drug Interactions,Hematologic Neoplasms,Humans,Pharmaceutical Preparations,Triazoles","note":"Cited By :7 \\par Cited By :7 \\par Export Date: 20 November 2022 \\par Export Date: 20 November 2022","file":"/Users/russelllewis/Zotero/storage/7IQW4ADS/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf;/Users/russelllewis/Zotero/storage/XREGA4SJ/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf","bibtex":"@article{bruggemann.etal_2022b,\n title = {Management of Drug--Drug Interactions of Targeted Therapies for Haematological Malignancies and Triazole Antifungal Drugs},\n author = {Br{\\\"u}ggemann, Roger J and Verheggen, Rebecca and Boerrigter, Emmy and Stanzani, Marta and Verweij, Paul E and Blijlevens, Nicole M A and Lewis, Russell E},\n year = {2022},\n month = jan,\n journal = {The Lancet Haematology},\n volume = {9},\n number = {1},\n pages = {e58-e72},\n issn = {23523026},\n doi = {10.1016/S2352-3026(21)00232-5},\n urldate = {2022-02-25},\n langid = {english},\n keywords = {Aged,Antifungal Agents,Drug Interactions,Hematologic Neoplasms,Humans,Pharmaceutical Preparations,Triazoles},\n note = {Cited By :7\n\\par\nCited By :7\n\\par\nExport Date: 20 November 2022\n\\par\nExport Date: 20 November 2022},\n file = {/Users/russelllewis/Zotero/storage/7IQW4ADS/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf;/Users/russelllewis/Zotero/storage/XREGA4SJ/Brüggemann et al. - 2022 - Management of drug–drug interactions of targeted t.pdf}\n}\n\n","author_short":["Brüggemann, R. J","Verheggen, R.","Boerrigter, E.","Stanzani, M.","Verweij, P. E","Blijlevens, N. M A","Lewis, R. E"],"key":"bruggemann.etal_2022b","id":"bruggemann.etal_2022b","bibbaseid":"brggemann-verheggen-boerrigter-stanzani-verweij-blijlevens-lewis-managementofdrugdruginteractionsoftargetedtherapiesforhaematologicalmalignanciesandtriazoleantifungaldrugs-2022","role":"author","urls":{},"keyword":["Aged","Antifungal Agents","Drug Interactions","Hematologic Neoplasms","Humans","Pharmaceutical Preparations","Triazoles"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/a6GBPjh3wXfA46RXX/CV.bib","dataSources":["jKN7prtxaY9N8vqst","qLqjc4bwMYLmk2F3c","8E62bsJiEchQrmW6z"],"keywords":["aged","antifungal agents","drug interactions","hematologic neoplasms","humans","pharmaceutical preparations","triazoles"],"search_terms":["management","drug","drug","interactions","targeted","therapies","haematological","malignancies","triazole","antifungal","drugs","brüggemann","verheggen","boerrigter","stanzani","verweij","blijlevens","lewis"],"title":"Management of Drug–Drug Interactions of Targeted Therapies for Haematological Malignancies and Triazole Antifungal Drugs","year":2022}